News

Don't catch a falling knife.

HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.

Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.

Today, July 30, 2026, investors are pivoting back into technology despite GDP slowdown, with the Nasdaq climbing on broad semiconductor strength.

TDOC tops adjusted earnings estimates despite a revenue miss, as Integrated Care and international growth help cushion BetterHelp weakness and a lower 2026 outlook.

Teladoc Health (NYSE:TDOC) has entered a new partnership with Walmart to embed its virtual care services into Walmart's retail platforms. The collaboration extends Teladoc's reach into both retail and institutional channels through Walmart's broad footprint. The company continues to emphasize a path toward consistent profitability following periods of net losses. Teladoc Health sits at an interesting point, with the stock trading around $9.07 and showing mixed recent performance. The share...

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

It could be an attractive contrarian play, but beware of the risks.

In late May 2026, Walmart announced that Teladoc Health’s virtual urgent care, dermatology, and nutrition services are now available on its Better Care Services platform, offering both insured and US$89 cash‑pay visits with integrated pharmacy fulfillment across nearly 5,000 locations. This partnership broadens Teladoc’s retail footprint and reinforces its push to meet patients on large consumer platforms, complementing January’s launch of BetterHelp mental health services on Walmart’s care...

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 11.3% in the afternoon session after it announced its virtual care services are now available through Walmart's Better Care Services platform.

Teladoc’s Walmart partnership is the latest step in its push to embed its services with retailers and platforms Americans already use.

It would be quite the feat for this struggling company.

Teladoc currently trades at $6.81 per share and has shown little upside over the past six months, posting a small loss of 1.6%. The stock also fell short of the S&P 500’s 9.9% gain during that period.

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 7.1% in the afternoon session after the stock's positive momentum continued as it raised its price target on the stock to $9.00 from $8.25 and maintained a Buy rating.

Teladoc (TDOC) delivered earnings and revenue surprises of -13.82% and +0.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?